Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
14
9
2020
medline:
14
9
2020
entrez:
13
9
2020
Statut:
ppublish
Résumé
The authors of the above mentioned article would like to highlight the following corrections, based upon recent changes to the FDA label and guidance on the use of belamaf.
Identifiants
pubmed: 32920777
doi: 10.1007/s40123-020-00289-z
pii: 10.1007/s40123-020-00289-z
pmc: PMC7708532
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
913-915Commentaires et corrections
Type : ErratumFor